Sinovac Biotech Ltd. (SVA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 464.94M |
| Enterprise Value | -184.52M |
| P/E Ratio | -7.8 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 1.2 |
| Price/Book Ratio | 0.1 |
| Enterprise/Revenue | -0.48 |
| Enterprise/EBITDA | 0.98 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.15 |
| Operating Margin | -0.75 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 386.01M |
| Revenue/Share | 5.37 |
| Gross Profit | 261.98M |
| EBITDA | -187.66M |
| Net Income | -59.68M |
| Diluted EPS | -0.83 |
Balance Sheet
| Total Cash | 5.97B |
| Total Cash/Share | 92.39 |
| Total Debt | 505.62M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 4.59 |
| Book Value Per Share | 89.09 |
Price History
| 52-Week Change | 0 |
| 52-Week High | 6.47 |
| 52-Week Low | 6.47 |
| Moving Average 50 Days | 6.47 |
| Moving Average 200 Days | 6.47 |
Statistics
| Average Volume | 0 |
| Shares Outstanding | 71.86M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -58.87 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
